- Home
- CADL vs EVM Comparison
CADL vs EVM Comparison
Compare CADL & EVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- EVM
- Stock Information
- Founded
- CADL 1999
- EVM 2002
- Country
- CADL United States
- EVM United States
- Employees
- CADL N/A
- EVM N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- EVM Finance/Investors Services
- Sector
- CADL Health Care
- EVM Finance
- Exchange
- CADL Nasdaq
- EVM Nasdaq
- Market Cap
- CADL 234.8M
- EVM 219.2M
- IPO Year
- CADL 2021
- EVM N/A
- Fundamental
- Price
- CADL $4.81
- EVM $9.02
- Analyst Decision
- CADL Strong Buy
- EVM
- Analyst Count
- CADL 4
- EVM 0
- Target Price
- CADL $21.00
- EVM N/A
- AVG Volume (30 Days)
- CADL 854.0K
- EVM 55.8K
- Earning Date
- CADL 05-20-2025
- EVM 01-01-0001
- Dividend Yield
- CADL N/A
- EVM 4.01%
- EPS Growth
- CADL N/A
- EVM N/A
- EPS
- CADL N/A
- EVM 0.20
- Revenue
- CADL N/A
- EVM N/A
- Revenue This Year
- CADL N/A
- EVM N/A
- Revenue Next Year
- CADL N/A
- EVM N/A
- P/E Ratio
- CADL N/A
- EVM $47.61
- Revenue Growth
- CADL N/A
- EVM N/A
- 52 Week Low
- CADL $3.79
- EVM $7.67
- 52 Week High
- CADL $14.60
- EVM $9.59
- Technical
- Relative Strength Index (RSI)
- CADL 42.39
- EVM 51.18
- Support Level
- CADL $4.34
- EVM $8.89
- Resistance Level
- CADL $5.34
- EVM $9.14
- Average True Range (ATR)
- CADL 0.33
- EVM 0.13
- MACD
- CADL 0.10
- EVM 0.04
- Stochastic Oscillator
- CADL 47.11
- EVM 73.33
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income and alternative strategies to institutional investors, both in the United States and internationally.